Invention Grant
- Patent Title: Sustained release delivery systems comprising traceless linkers
-
Application No.: US15957474Application Date: 2018-04-19
-
Publication No.: US10751417B2Publication Date: 2020-08-25
- Inventor: Christopher M. Adams , Myriam April , Tanzina Fazal , Cornelia Jutta Forster , Edward Charles Hall , Cameron Chuck-munn Lee
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Asha K. Nadipuram
- Main IPC: A61K47/36
- IPC: A61K47/36 ; A61K47/61 ; A61K47/69 ; A61P27/02 ; A61K9/00 ; A61K31/496 ; A61K47/10 ; A61K47/22
Abstract:
Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related thereto, pharmaceutical compositions comprising the drug delivery systems, and the use of the drug delivery systems as sustained release therapeutics.
Public/Granted literature
- US20180303945A1 SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS Public/Granted day:2018-10-25
Information query
